Literature DB >> 20053388

Inhibition of PHOSPHO1 activity results in impaired skeletal mineralization during limb development of the chick.

Vicky E Macrae1, Megan G Davey, Lynn McTeir, Sonoko Narisawa, Manisha C Yadav, Jose Luis Millan, Colin Farquharson.   

Abstract

PHOSPHO1 is a bone-specific phosphatase implicated in the initiation of inorganic phosphate generation for matrix mineralization. The control of mineralization is attributed to the actions of tissue-nonspecific alkaline phosphatase (TNAP). However, matrix vesicles (MVs) containing apatite crystals are present in patients with hypophosphatasia as well as TNAP null (Akp2(-/-)) mice. It is therefore likely that other phosphatases work with TNAP to regulate matrix mineralization. Although PHOSPHO1 and TNAP expression is associated with MVs, it is not known if PHOSPHO1 and TNAP are coexpressed during the early stages of limb development. Furthermore, the functional in vivo role of PHOSPHO1 in matrix mineralization has yet to be established. Here, we studied the temporal expression and functional role of PHOSPHO1 within chick limb bud mesenchymal micromass cultures and also in wild-type and talpid(3) chick mutants. These mutants are characterized by defective hedgehog signalling and the absence of endochondral mineralization. The ability of in vitro micromass cultures to differentiate and mineralize their matrix was temporally associated with increased expression of PHOSPHO1 and TNAP. Comparable changes in expression were noted in developing embryonic legs (developmental stages 23-36HH). Micromass cultures treated with lansoprazole, a small-molecule inhibitor of PHOSPHO1 activity, or FGF2, an inhibitor of chondrocyte differentiation, resulted in reduced alizarin red staining (P<0.05). FGF2 treatment also caused a reduction in PHOSPHO1 (P<0.001) and TNAP (P<0.001) expression. Expression analysis by whole-mount RNA in situ hybridization correlated with qPCR micromass data and demonstrated the existence of a tightly regulated pattern of Phospho1 and Tnap expression which precedes mineralization. Treatment of developing embryos for 5 days with lansoprazole completely inhibited mineralization of all leg and wing long bones as assessed by alcian blue/alizarin red staining. Furthermore, long bones of the talpid(3) chick mutant did not express Phospho1 or Tnap whereas flat bones mineralized normally and expressed both phosphatases. In conclusion, this study has disclosed that PHOSPHO1 expression mirrors that of TNAP during embryonic bone development and that PHOSPHO1 contributes to bone mineralization in developing chick long bones. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alkaline Phosphatase; PHOSPHO1; chondrocyte differentiation; mineralization; talpid3

Mesh:

Substances:

Year:  2010        PMID: 20053388      PMCID: PMC2842458          DOI: 10.1016/j.bone.2009.12.018

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  53 in total

1.  A series of normal stages in the development of the chick embryo.

Authors:  V HAMBURGER; H L HAMILTON
Journal:  J Morphol       Date:  1951-01       Impact factor: 1.804

2.  Can biological calcification occur in the presence of pyrophosphate?

Authors:  J L Meyer
Journal:  Arch Biochem Biophys       Date:  1984-05-15       Impact factor: 4.013

3.  Inactivation of two mouse alkaline phosphatase genes and establishment of a model of infantile hypophosphatasia.

Authors:  S Narisawa; N Fröhlander; J L Millán
Journal:  Dev Dyn       Date:  1997-03       Impact factor: 3.780

4.  31P NMR studies of resting zone cartilage from growth plate.

Authors:  B J Kvam; P Pollesello; F Vittur; S Paoletti
Journal:  Magn Reson Med       Date:  1992-06       Impact factor: 4.668

5.  Morphological and biochemical characterization of mineralizing primary cultures of avian growth plate chondrocytes: evidence for cellular processing of Ca2+ and Pi prior to matrix mineralization.

Authors:  L N Wu; Y Ishikawa; G R Sauer; B R Genge; F Mwale; H Mishima; R E Wuthier
Journal:  J Cell Biochem       Date:  1995-02       Impact factor: 4.429

6.  Phosphodiesterase activity is a novel property of alkaline phosphatase from osseous plate.

Authors:  A A Rezende; J M Pizauro; P Ciancaglini; F A Leone
Journal:  Biochem J       Date:  1994-07-15       Impact factor: 3.857

7.  Extracellular nucleotides block bone mineralization in vitro: evidence for dual inhibitory mechanisms involving both P2Y2 receptors and pyrophosphate.

Authors:  Isabel R Orriss; Jennifer C Utting; Andrea Brandao-Burch; Kay Colston; Barbara R Grubb; Geoffrey Burnstock; Timothy R Arnett
Journal:  Endocrinology       Date:  2007-06-14       Impact factor: 4.736

8.  Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization.

Authors:  Lovisa Hessle; Kristen A Johnson; H Clarke Anderson; Sonoko Narisawa; Adnan Sali; James W Goding; Robert Terkeltaub; José Luis Millan
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-24       Impact factor: 11.205

9.  Concerted regulation of inorganic pyrophosphate and osteopontin by akp2, enpp1, and ank: an integrated model of the pathogenesis of mineralization disorders.

Authors:  Dympna Harmey; Lovisa Hessle; Sonoko Narisawa; Kristen A Johnson; Robert Terkeltaub; José Luis Millán
Journal:  Am J Pathol       Date:  2004-04       Impact factor: 4.307

10.  Elevated skeletal osteopontin levels contribute to the hypophosphatasia phenotype in Akp2(-/-) mice.

Authors:  Dympna Harmey; Kristen A Johnson; Jonathan Zelken; Nancy P Camacho; Marc F Hoylaerts; Masaki Noda; Robert Terkeltaub; José Luis Millán
Journal:  J Bone Miner Res       Date:  2006-09       Impact factor: 6.741

View more
  33 in total

1.  Identification of novel regulators of osteoblast matrix mineralization by time series transcriptional profiling.

Authors:  Katherine Ann Staines; Dongxing Zhu; Colin Farquharson; Vicky Elizabeth MacRae
Journal:  J Bone Miner Metab       Date:  2013-08-08       Impact factor: 2.626

2.  Lectins influence chondrogenesis and osteogenesis in limb bud mesenchymal cells.

Authors:  Tahereh Talaei-Khozani; Malihezaman Monsefi; Mansoureh Ghasemi
Journal:  Glycoconj J       Date:  2011-03-01       Impact factor: 2.916

Review 3.  Mechanism of Bone Mineralization.

Authors:  Monzur Murshed
Journal:  Cold Spring Harb Perspect Med       Date:  2018-12-03       Impact factor: 6.915

4.  Role of PHOSPHO1 in Periodontal Development and Function.

Authors:  L E Zweifler; M Ao; M Yadav; P Kuss; S Narisawa; T N Kolli; H F Wimer; C Farquharson; M J Somerman; J L Millán; B L Foster
Journal:  J Dent Res       Date:  2016-03-25       Impact factor: 6.116

5.  An investigation of the mineral in ductile and brittle cortical mouse bone.

Authors:  Naiara Rodriguez-Florez; Esther Garcia-Tunon; Quresh Mukadam; Eduardo Saiz; Karla J Oldknow; Colin Farquharson; José Luis Millán; Alan Boyde; Sandra J Shefelbine
Journal:  J Bone Miner Res       Date:  2015-05       Impact factor: 6.741

6.  A distinctive patchy osteomalacia characterises Phospho1-deficient mice.

Authors:  Alan Boyde; Katherine A Staines; Behzad Javaheri; Jose Luis Millan; Andrew A Pitsillides; Colin Farquharson
Journal:  J Anat       Date:  2017-08       Impact factor: 2.610

7.  Overlapping functions of bone sialoprotein and pyrophosphate regulators in directing cementogenesis.

Authors:  M Ao; M B Chavez; E Y Chu; K C Hemstreet; Y Yin; M C Yadav; J L Millán; L W Fisher; H A Goldberg; M J Somerman; B L Foster
Journal:  Bone       Date:  2017-09-01       Impact factor: 4.398

8.  Enhanced phosphocholine metabolism is essential for terminal erythropoiesis.

Authors:  Nai-Jia Huang; Ying-Cing Lin; Chung-Yueh Lin; Novalia Pishesha; Caroline A Lewis; Elizaveta Freinkman; Colin Farquharson; José Luis Millán; Harvey Lodish
Journal:  Blood       Date:  2018-04-30       Impact factor: 22.113

9.  PHOSPHO1 is essential for mechanically competent mineralization and the avoidance of spontaneous fractures.

Authors:  Carmen Huesa; Manisha C Yadav; Mikko A J Finnilä; Simon R Goodyear; Simon P Robins; K Elizabeth Tanner; Richard M Aspden; José Luis Millán; Colin Farquharson
Journal:  Bone       Date:  2011-01-25       Impact factor: 4.398

10.  Pharmacological inhibition of PHOSPHO1 suppresses vascular smooth muscle cell calcification.

Authors:  Tina Kiffer-Moreira; Manisha C Yadav; Dongxing Zhu; Sonoko Narisawa; Campbell Sheen; Boguslaw Stec; Nicholas D Cosford; Russell Dahl; Colin Farquharson; Marc F Hoylaerts; Vicky E Macrae; José Luis Millán
Journal:  J Bone Miner Res       Date:  2013-01       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.